PE02.16LB Improved potency, breadth, and pharmacokinetics of VRC01-class antibodies for HIV-1 prevention and treatmentE-posterBroadly neutralizing antibodies
PE02.17LB A lineage of exceptionally potent and broad BnAbs with ultralong CDRH3 from vaccinated cows focus low-mutation rate from germline into a globular knob contacting the CD4bsE-posterBroadly neutralizing antibodies
PE03.01 Breadth of CD8 T-cell mediated inhibition of HIV-1 replication correlates with breadth of epitope recognition mapped with a comprehensive Gag, Nef, Env and Pol potential T-cell Epitope (PTE) peptide setE-posterCellular immunity
PE03.03 Incidence, clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome (IRIS) among HIV patients on highly active anti-retroviral therapy (HAART) in the south west region of CameroonE-posterCellular immunity
PE03.04LB Infection with a highly Gag pre-adapted virus broadens the proteins targeted by CTLs during acute HIV infectionE-posterCellular immunity
PE04.01 Correlates of dapivirine vaginal ring uptake among women participating in an open label extension trial-MTN-025/HOPEE-posterClinical trial results
PE04.02 Tenofovir-only and tenofovir/levonorgestrel intravaginal rings are unlikely to impact the genital microbiota of sub-Saharan womenE-posterClinical trial results
PE04.03LB Phase 1 evaluation of the safety, acceptability, and pharmacokinetic profile of an OB-002H gelE-posterClinical trial results
PE04.04LB Can the offer of regular HIV self-testing kits reduce time to HIV diagnosis in MSM? Results from the SELPHI RCTE-posterClinical trial results
PE04.05LB Can a theory-based SMS intervention improve the health service utilization of female entertainment workers in Cambodia? Findings from the Mobile Link Randomized Controlled TrialE-posterClinical trial results
seek-warrow-warrow-eseek-e181 - 190 of 444 items